• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    DIH Holdings US Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Financial Statements and Exhibits

    11/14/24 4:51:21 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email
    8-K
    false00018837880001883788dhai:PublicWarrantsMember2024-11-142024-11-1400018837882024-11-142024-11-140001883788us-gaap:CommonClassAMember2024-11-142024-11-14

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): November 14, 2024

     

     

    DIH HOLDING US, INC.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-41250

    98-1624542

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    77 Accord Park Drive;

    Suite D-1

     

    Norwell, Massachusetts

     

    02061

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 877 944-2200

     

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐

     

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐

     

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐

     

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐

     

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Class A Common Stock

     

    DHAI

     

    The Nasdaq Stock Market LLC

    Warrants

     

    DHAIW

     

    The Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☒

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


     

    Item 2.02 Results of Operations and Financial Condition.

    On November 14, 2024, DIH Holding US, Inc. (the “Company”) issued a press release reporting its results of operations for the fiscal quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

    Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

    On November 14, 2024, the Audit Committee of the Board of Directors (the “Audit Committee”) of the Company, in consultation with Company management, determined that the Company’s interim financial statements (collectively, the “Prior Period Financial Statements”) as of and for the three months ended June 30, 2024 (the “Non-Reliance Period”) included in the Company’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission (“SEC”) on August 19, 2024 (the “Form 10-Q”) and in the Company’s Registration Statement on Form S-1 which was initially filed with the SEC on July 26, 2024 and declared effective by the SEC on October 18, 2024 (the “Form S-1”) should no longer be relied upon. Management and the Audit Committee have determined that the errors (described below) in the unaudited interim consolidated financial statements for the Non-Reliance Period require a restatement of the Prior Period Financial Statements (the “Restatement”). The previously filed Form 10-Q for the Prior Period Financial Statements has not been amended yet. Accordingly, investors should no longer rely upon the Company’s Prior Period Financial Statements for this period and any earnings releases, investor presentations or other communications relating to this period.

    During the preparation of the Company’s financial statements as of and for the three and six months ended September 30, 2024, the Company identified two device sales and related cost of sales which should have been recognized in the quarter ended June 30, 2024 when the transfer of control occurred. The device sales had erroneously not been recorded in the originally issued Form 10-Q. The errors in the unaudited condensed consolidated financial statements for the June 30, 2024 Non-Reliance Periods noted above will be corrected in the restated financial statements for the June 30, 2024 Non-Reliance Period in an amendment to the previously-filed Form 10-Q and a Post-Effective Amendment to the Form S-1.

    As the Company is restating the June 30, 2024 Non-Reliance Period, we are taking the opportunity to adjust for immaterial adjustments identified during the current review period, or were passed in the prior review period.

    The Audit Committee and management of the Company have discussed the matters disclosed in this Item 4.02(a) with BDO AG, the Company’s independent registered public accounting firm as of the date of the filing.

    Item 9.01 Financial Statements and Exhibits.

    (a)-(b) Financial Statements.

    (c) Exhibits.

     

    99.1

    Release dated November 14, 2024

    104

    Cover Page Interactive Data File (Formatted in Inline XBRL)

     


     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    DIH HOLDING US, INC.

     

     

     

     

    Date:

    November 14, 2024

    By:

     /s/ Jason Chen

     

     

     

    Jason Chen
    Chief Executive Officer and Chairman
     

     


    Get the next $DHAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 6:07:49 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

      SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

      11/14/24 12:46:18 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13D filed by DIH Holdings US Inc.

      SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

      2/20/24 5:18:47 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DIH Announces Third Quarter 2025 Financial Results

      NORWELL, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the third fiscal quarter ended December 31, 2024. Recent Highlights Revenue of $15.1 million for the quarter ended December 31, 2024, representing a decline of 21% over the prior year periodDevice revenue of $11.7 million and service reven

      2/14/25 5:07:01 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Expands Strategic Partnership with Zahrawi Group

      NORWELL, Mass. and DUBAI, United Arab Emirates, Feb. 04, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the expansion of their strategic partnership with Zahrawi Group (MTC Company), DIH's representative and sales partner, to include Saudi Arabia.  Building on a successful collaboration that started in 2019, the partnership now spans four countries: th

      2/4/25 8:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Announces Closing of $4.6 Million Public Offering

      NORWELL, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the closing of its previously announced public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock and one Class A warrant to purchase one share of Class A common stock

      2/3/25 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    See more
    • DIH Appoints Shepherd Center as a DIH Center of Excellence

      NORWELL, Mass. and ATLANTA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Shepherd Center as DIH Center of Excellence. Through this partnership, DIH and Shepherd Center aim to further enhance rehabilitation outcomes and drive advancements in rehabilitation, creating new opportunities for patient recovery. The DIH Center of

      12/23/24 7:00:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Sheltering Arms Institute as a DIH Center of Excellence

      NORWELL, Mass. and RICHMOND, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the designation of Sheltering Arms Institute, a collaboration with VCU Health, as DIH Center of Excellence. By partnering with Sheltering Arms Institute, DIH continues to build a strong presence among top-tier healthcare providers dedicated to enhancing patient re

      12/16/24 4:05:00 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Appoints Dietmar Dold as Chief Operating Officer

      NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately.  Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil

      11/4/24 8:17:00 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    SEC Filings

    See more
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      6/9/25 4:35:36 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • SEC Form 424B3 filed by DIH Holdings US Inc.

      424B3 - DIH HOLDING US, INC. (0001883788) (Filer)

      6/9/25 4:30:35 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • DIH Holdings US Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - DIH HOLDING US, INC. (0001883788) (Filer)

      5/30/25 7:49:50 AM ET
      $DHAI
      Medical/Dental Instruments
      Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Baucus Max was granted 52,817 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:26 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Chen Cathryn was granted 105,634 shares and acquired 4,885,173 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care
    • Director Eberts F Samuel Iii was granted 105,634 shares (SEC Form 4)

      4 - DIH HOLDING US, INC. (0001883788) (Issuer)

      12/9/24 4:03:23 PM ET
      $DHAI
      Medical/Dental Instruments
      Health Care